Medtronic is recalling more than 322,000 of its insulin pumps because of a missing or broken component that can lead to over- or under-delivery of insulin. The problem is linked to one death, according to the U.S. Food and Drug Administration.
The recall is a “class I” recall, which the FDA says is “the most serious type of recall.”
